Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors
Type
ArticleAuthors
Tornatore, LauraSandomenico, Annamaria
Raimondo, Domenico
Low, Caroline
Rocci, Alberto
Tralau-Stewart, Cathy
Capece, Daria
D’Andrea, Daniel
Bua, Marco
Boyle, Eileen
van Duin, Mark
Zoppoli, Pietro
Jaxa-Chamiec, Albert
Thotakura, Anil K.
Dyson, Julian
Walker, Brian A.
Leonardi, Antonio
Chambery, Angela
Driessen, Christoph
Sonneveld, Pieter
Morgan, Gareth
Palumbo, Antonio
Tramontano, Anna
Rahemtulla, Amin
Ruvo, Menotti
Franzoso, Guido
KAUST Grant Number
KUK-I1-012-43Date
2014-12Permanent link to this record
http://hdl.handle.net/10754/597719
Metadata
Show full item recordCitation
Tornatore L, Sandomenico A, Raimondo D, Low C, Rocci A, et al. (2014) Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors. Cancer Cell 26: 938. Available: http://dx.doi.org/10.1016/j.ccell.2014.11.021.Sponsors
We thank G. Inghirami, F. Dazzi, R. Orlowski, I. Kuiatse, L. Bergsagel, H. Auner, K. Parzych, and A. Karadimitris for cell lines; L. De Colibus, A. De Simone, E. Bellone, and M. Gambella for analytical or technical assistance; G. Cruciani for access to FLAP; and P. Omedè for primary PC samples. We also thank A. Iavarone for critical experimental advice and U. Siebenlist, K. Kelly, M. Lenardo, M. Pagano, H. Walczak, G. Acton, L. Busino, A. De Simone, and E. Tate for critical reading of the manuscript. The work was supported in part by Medical Research Council grants G0901436 and MR/L005069/1, NIH grants CA084040 and CA098583, Cancer Research UK grants A8839 and A15115, and an Imperial Innovations grant to G.F.; Project MERIT FIRB No. RBNE08NKH7_003 to M.R.; King Abdullah University of Science and Technology award KUK-I1-012-43 and PRIN 20108XYHJS to A.T.; and a PRIN 2009 grant to A.P.Publisher
Elsevier BVJournal
Cancer Cellae974a485f413a2113503eed53cd6c53
10.1016/j.ccell.2014.11.021